. 2019 Mar 15;20:144. doi: 10.1186/s12859-019-2705-9

Table 1.

Setting of simulation parameters

Group/group	α _g	β _gj	γ _ig	ρ _ig	ε _ijg
Study 1: Control	$N (0, 1)$	0	$N (0, 1)$	InvGamma(1,1)	$N (0, 1)$
Study 1: Disease A	$N (0, 1)$	$N (0, 1)$	$N (0, 1)$	InvGamma(1,1)	$N (0, 1)$
Study 2: Control	$N (0, 1)$	0	$N (2, 1)$	InvGamma(1,2)	$N (0, 1)$
Study 2: Disease B	$N (0, 1)$	$N (0, 1)$	$N (2, 1)$	InvGamma(1,2)	$N (0, 1)$
Study 3: Control	$N (0, 1)$	0	$N (0, 1)$	InvGamma(1,1)	$N (0, 1)$
Study 3: Disease A	$N (0, 1)$	$N (0, 1)$	$N (0, 1)$	InvGamma(1,1)	$N (0, 1)$
Study 4: Control	$N (0, 1)$	0	$N (0, 1)$	InvGamma(1,1)	$N (0, 1)$
Study 4: Disease A	$N (0, 1)$	$N (0, 1)$	$N (0, 1)$	InvGamma(1,1)	$N (0, 1)$

Simulation nos. 1a and 1b involve studies 1 and 2, only, while simulation no. 2 involves all four studies